Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis

Neurology. 2010 May 11;74(19):1550-1. doi: 10.1212/WNL.0b013e3181dd41a1.

Authors

L C Wong-Kisiel¹, T Ji, D L Renaud, S Kotagal, M C Patterson, J Dalmau, K J Mack

Affiliation

¹ Department of Neurology and Pediatrics, Mayo Clinic Foundation and College of Medicine, Rochester, MN 55905,USA. mack.kenneth@mayo.edu

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antibodies, Monoclonal, Murine-Derived
Anticonvulsants / therapeutic use
Autoantibodies / blood
Autoimmune Diseases of the Nervous System / drug therapy*
Autoimmune Diseases of the Nervous System / immunology*
Autoimmune Diseases of the Nervous System / physiopathology
Brain / drug effects
Brain / immunology
Brain / physiopathology
Dyskinesias / etiology
Encephalitis / drug therapy*
Encephalitis / immunology*
Encephalitis / physiopathology
Exanthema / etiology
Humans
Immunoglobulins, Intravenous / therapeutic use
Immunotherapy / methods*
Infant
Male
Methylprednisolone / therapeutic use
Receptors, N-Methyl-D-Aspartate / immunology*
Rituximab
Seizures / etiology
Spasm / etiology
Treatment Outcome

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Anticonvulsants
Autoantibodies
Immunoglobulins, Intravenous
Receptors, N-Methyl-D-Aspartate
Rituximab
Methylprednisolone